@Article{Ovens2022,
  author    = {Ovens, Ashley J. and Gee, Yi Sing and Ling, Naomi X.Y. and Yu, Dingyi and Hardee, Justin P. and Chung, Jin D. and Ngoei, Kevin R.W. and Waters, Nicholas J. and Hoffman, Nolan J. and Scott, John W. and Loh, Kim and Spengler, Katrin and Heller, Regine and Parker, Michael W. and Lynch, Gordon S. and Huang, Fei and Galic, Sandra and Kemp, Bruce E. and Baell, Jonathan B. and Oakhill, Jonathan S. and Langendorf, Christopher G.},
  journal   = {Biochemical Journal},
  title     = {Structure-function analysis of the AMPK activator SC4 and identification of a potent pan AMPK activator},
  year      = {2022},
  issn      = {1470-8728},
  month     = jun,
  number    = {11},
  pages     = {1181--1204},
  volume    = {479},
  doi       = {10.1042/bcj20220067},
  groups    = {AMPK},
  publisher = {Portland Press Ltd.},
}

@Article{Gong2012,
  author    = {Gong, Li and Goswami, Srijib and Giacomini, Kathleen M. and Altman, Russ B. and Klein, Teri E.},
  journal   = {Pharmacogenetics and Genomics},
  title     = {Metformin pathways: pharmacokinetics and pharmacodynamics},
  year      = {2012},
  issn      = {1744-6872},
  month     = nov,
  number    = {11},
  pages     = {820--827},
  volume    = {22},
  doi       = {10.1097/fpc.0b013e3283559b22},
  groups    = {Metformin},
  publisher = {Ovid Technologies (Wolters Kluwer Health)},
}

@Article{Xiao2007,
  author    = {Xiao, Bing and Heath, Richard and Saiu, Peter and Leiper, Fiona C. and Leone, Philippe and Jing, Chun and Walker, Philip A. and Haire, Lesley and Eccleston, John F. and Davis, Colin T. and Martin, Stephen R. and Carling, David and Gamblin, Steven J.},
  journal   = {Nature},
  title     = {Structural basis for AMP binding to mammalian AMP-activated protein kinase},
  year      = {2007},
  issn      = {1476-4687},
  month     = sep,
  number    = {7161},
  pages     = {496--500},
  volume    = {449},
  doi       = {10.1038/nature06161},
  groups    = {AMPK},
  publisher = {Springer Science and Business Media LLC},
}

@Article{Steinberg2022,
  author    = {Steinberg, Gregory R. and Hardie, D. Grahame},
  journal   = {Nature Reviews Molecular Cell Biology},
  title     = {New insights into activation and function of the AMPK},
  year      = {2022},
  issn      = {1471-0080},
  month     = oct,
  number    = {4},
  pages     = {255--272},
  volume    = {24},
  doi       = {10.1038/s41580-022-00547-x},
  groups    = {AMPK},
  publisher = {Springer Science and Business Media LLC},
}

@Article{Liu2023,
  author    = {Liu, Changxing and Guo, Xinyi and Zhou, Yabin and Wang, He},
  journal   = {Journal of Inflammation Research},
  title     = {AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine},
  year      = {2023},
  issn      = {1178-7031},
  month     = nov,
  pages     = {5451--5464},
  volume    = {Volume 16},
  doi       = {10.2147/jir.s441597},
  groups    = {AMPK},
  publisher = {Informa UK Limited},
}

@Article{Sung2024,
  author    = {Sung, Jin Young and Kim, Seul Gi and Park, So-Young and Kim, Jae-Ryong and Choi, Hyoung Chul},
  journal   = {Experimental &amp; Molecular Medicine},
  title     = {Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway},
  year      = {2024},
  issn      = {2092-6413},
  month     = sep,
  doi       = {10.1038/s12276-024-01297-w},
  groups    = {Metformin},
  publisher = {Springer Science and Business Media LLC},
}

﻿
@Article{Lei2017,
  author                     = {Lei, Yong and Yi, Yanhua and Liu, Yang and Liu, Xia and Keller, Evan T. and Qian, Chao-Nan and Zhang, Jian and Lu, Yi},
  journal                    = {Chinese Journal of Cancer},
  title                      = {Metformin targets multiple signaling pathways in cancer},
  year                       = {2017},
  issn                       = {1000-467X},
  month                      = {JAN 26},
  volume                     = {36},
  abstract                   = {Metformin, an inexpensive and well-tolerated oral agent commonly used in
   the first-line treatment of type 2 diabetes, has become the focus of
   intense research as a candidate anticancer agent. Here, we discuss the
   potential of metformin in cancer therapeutics, particularly its
   functions in multiple signaling pathways, including AMP-activated
   protein kinase, mammalian target of rapamycin, insulin-like growth
   factor, c-Jun N-terminal kinase/mitogen-activated protein kinase (p38
   MAPK), human epidermal growth factor receptor-2, and nuclear factor
   kappaB pathways. In addition, cutting-edge targeting of cancer stem
   cells by metformin is summarized.},
  address                    = {651 DONGFENG RD E, GUANGZHOU, GUANGDONG 510060, PEOPLES R CHINA},
  affiliation                = {Zhang, J; Lu, Y (Corresponding Author), Minist Educ, Key Lab Longev \& Ageing Related Dis, Nanning 530021, Guangxi, Peoples R China. Zhang, J; Lu, Y (Corresponding Author), Guangxi Med Univ, Ctr Translat Med, 14th Floor,Pharmacol \& Biomed Sci Bldg, Nanning 530021, Guangxi, Peoples R China. Zhang, J (Corresponding Author), Univ Michigan, Sch Med, Dept Urol \& Pathol, Ann Arbor, MI 48109 USA. Lei, Yong; Liu, Yang; Liu, Xia; Zhang, Jian; Lu, Yi, Minist Educ, Key Lab Longev \& Ageing Related Dis, Nanning 530021, Guangxi, Peoples R China. Lei, Yong; Liu, Yang; Liu, Xia; Zhang, Jian; Lu, Yi, Guangxi Med Univ, Ctr Translat Med, 14th Floor,Pharmacol \& Biomed Sci Bldg, Nanning 530021, Guangxi, Peoples R China. Yi, Yanhua, Guangxi Med Univ, Sch Int Educ, Nanning 530021, Guangxi, Peoples R China. Keller, Evan T.; Zhang, Jian, Univ Michigan, Sch Med, Dept Urol \& Pathol, Ann Arbor, MI 48109 USA. Qian, Chao-Nan, Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Collaborat Innovat Ctr Canc Med,State Key Lab Onc, Guangzhou 510060, Guangdong, Peoples R China.},
  affiliations               = {Guangxi Medical University; Guangxi Medical University; University of Michigan System; University of Michigan; Sun Yat Sen University},
  article-number             = {17},
  author-email               = {jianzhang008@hotmail.com luyi5555@hotmail.com},
  cited-references           = {Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003. Algire C, 2011, ONCOGENE, V30, P1174, DOI 10.1038/onc.2010.483. Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252. Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933. Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533. Arai M, 2010, J PHARMACOL EXP THER, V334, P206, DOI 10.1124/jpet.109.164970. Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299. Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236. Barrière G, 2013, ANTI-CANCER AGENT ME, V13, P333, DOI 10.2174/1871520611313020018. Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487. Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419. Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024. Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769. Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186. Blandino G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1859. Cazzaniga M, 2009, CANCER EPIDEM BIOMAR, V18, P701, DOI 10.1158/1055-9965.EPI-08-0871. Chaudhary SC, 2012, PHOTOCHEM PHOTOBIOL, V88, P1149, DOI 10.1111/j.1751-1097.2012.01165.x. Cheaib B, 2015, CHIN J CANCER, V34, P4, DOI 10.5732/cjc.014.10289. Checkley LA, 2014, CANCER PREV RES, V7, P54, DOI 10.1158/1940-6207.CAPR-13-0110. Cho SW, 2014, MOL CELL ENDOCRINOL, V393, P24, DOI 10.1016/j.mce.2014.05.021. Clemmons DR, 2007, GROWTH HORM IGF RES, V17, P265, DOI 10.1016/j.ghir.2007.01.004. Colquhoun AJ, 2012, PROSTATE CANCER P D, V15, P346, DOI 10.1038/pcan.2012.16. Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854. Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21. Deng XS, 2012, CELL CYCLE, V11, P367, DOI 10.4161/cc.11.2.18813. Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310. Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33. Engelman JA, 2010, CANCER PREV RES, V3, P1049, DOI 10.1158/1940-6207.CAPR-10-0178. Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013. Fasih A, 2014, RADIAT RES, V182, P50, DOI 10.1667/RR13568.1. Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.59. Frosina G, 2009, MOL CANCER RES, V7, P989, DOI 10.1158/1541-7786.MCR-09-0030. Gonzalez-Angulo AM, 2010, CLIN CANCER RES, V16, P1695, DOI 10.1158/1078-0432.CCR-09-1805. Gou SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063969. Green AS, 2010, BLOOD, V116, P4262, DOI 10.1182/blood-2010-02-269837. Grimaldi C, 2012, LEUKEMIA, V26, P91, DOI 10.1038/leu.2011.269. Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003. Han G, 2015, CANCER BIOL THER, V16, P77, DOI 10.4161/15384047.2014.987021. Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249. Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704. Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110. Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994. Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024. Honjo S, 2014, INT J ONCOL, V45, P567, DOI 10.3892/ijo.2014.2450. HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165. Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x. Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471. Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494. Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2. Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682. Jones RA, 2007, ONCOGENE, V26, P1636, DOI 10.1038/sj.onc.1209955. Jung M, 2001, SEMIN RADIAT ONCOL, V11, P346, DOI 10.1053/srao.2001.26034. Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014. Karnevi E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-235. Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x. Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418. Klubo-Gwiezdzinska J, 2012, ENDOCR-RELAT CANCER, V19, P447, DOI 10.1530/ERC-12-0046. Klümpen HJ, 2010, ONCOLOGIST, V15, P1262, DOI 10.1634/theoncologist.2010-0196. Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807. Lengyel E, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.026. Li L, 2014, CLIN CANCER RES, V20, P2714, DOI 10.1158/1078-0432.CCR-13-2613. Li X, 2011, J INT MED RES, V39, P358, DOI 10.1177/147323001103900203. Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814. Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7. Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200. Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811. Malaguarnera R, 2014, ENDOCRINOLOGY, V155, P1207, DOI 10.1210/en.2013-1925. Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009. McCampbell AS, 2006, CLIN CANCER RES, V12, P6373, DOI 10.1158/1078-0432.CCR-06-0912. McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001. Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055. Memmott RM, 2009, J CLIN ONCOL, V27, pE226, DOI 10.1200/JCO.2009.25.3963. Mohammed A, 2013, TRANSL ONCOL, V6, P649, DOI 10.1593/tlo.13556. Monteagudo S, 2012, NANOMEDICINE-UK, V7, P493, DOI {[}10.2217/nnm.11.61, 10.2217/NNM.11.61]. Morgillo F, 2013, CLIN CANCER RES, V19, P3508, DOI 10.1158/1078-0432.CCR-12-2777. Muaddi H, 2013, RADIOTHER ONCOL, V108, P446, DOI 10.1016/j.radonc.2013.06.014. Nahta R, 2010, CLIN BREAST CANCER, V10, pS72, DOI 10.3816/CBC.2010.s.015. Nangia-Makker P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084369. Niehr F, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-76. Ning JY, 2010, MOL ENDOCRINOL, V24, P1218, DOI 10.1210/me.2009-0474. Pan JX, 2012, CELL CYCLE, V11, P2314, DOI 10.4161/cc.20770. Panka DJ, 2006, CLIN CANCER RES, V12, p2371S, DOI 10.1158/1078-0432.CCR-05-2539. Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495. Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536. Qu C, 2014, MOL CELL BIOCHEM, V386, P63, DOI 10.1007/s11010-013-1845-x. Queiroz EAIF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098207. Quinn BJ, 2013, CANCER PREV RES, V6, P801, DOI 10.1158/1940-6207.CAPR-13-0058-T. Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221. Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167. Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243. Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229. Salani B, 2012, FASEB J, V26, P788, DOI 10.1096/fj.11-192088. Sharma A, 2006, CANCER RES, V66, P8200, DOI 10.1158/0008-5472.CAN-06-0809. Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869. Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781. Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007. Sheri A, 2010, CLIN BREAST CANCER, V10, pS79, DOI 10.3816/CBC.2010.s.016. Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13. Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362. Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86. Tseng SC, 2013, BIOCHEM PHARMACOL, V85, P583, DOI 10.1016/j.bcp.2012.12.001. Uehara T, 2015, ONCOL REP, V33, P744, DOI 10.3892/or.2014.3611. Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783. Vazquez-Martin A, 2009, ANN ONCOL, V20, P592, DOI 10.1093/annonc/mdn758. Vazquez-Martin A, ONCOL REP. Vazquez-Martin A, 2011, BREAST CANCER RES TR, V126, P355, DOI 10.1007/s10549-010-0924-x. Vazquez-Martin A, 2009, CELL CYCLE, V8, P788, DOI 10.4161/cc.8.5.7787. Vazquez-Martin A, 2009, CELL CYCLE, V8, P88, DOI 10.4161/cc.8.1.7499. Vitale-Cross L, 2012, CANCER PREV RES, V5, P562, DOI 10.1158/1940-6207.CAPR-11-0502. Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055587. Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410. Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI14178. Wu N, 2011, NEOPLASMA, V58, P482, DOI 10.4149/neo\_2011\_06\_482. Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016. Xu YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1178, DOI 10.1159/000354517. Yasmeen A, 2011, GYNECOL ONCOL, V121, P492, DOI 10.1016/j.ygyno.2011.02.021. Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6. Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500. Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9. Zhang Q, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.03.008. Zhang YM, 2014, ONCOTARGET, V5, P12936, DOI 10.18632/oncotarget.2683. Zhao D, 2015, INT J CANCER, V136, P2556, DOI 10.1002/ijc.29305. Zheng LY, 2013, CLIN CANCER RES, V19, P5372, DOI 10.1158/1078-0432.CCR-13-0203. Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137. Zhou W, 2013, CHIN J CANCER, V32, P427, DOI 10.5732/cjc.013.10086. Zi FM, 2014, CANC LETT B, V356, P443. Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025. Zordoky BNM, 2014, BBA-GEN SUBJECTS, V1840, P1943, DOI 10.1016/j.bbagen.2014.01.023.},
  da                         = {2024-09-05},
  doc-delivery-number        = {EN8ZL},
  doi                        = {10.1186/s40880-017-0184-9},
  eissn                      = {1944-446X},
  funding-acknowledgement    = {National Natural Science Foundation of China (NSFC) Key Project {[}81130046]; NSFC {[}81171993, 81272415]; Guangxi Key Projects {[}2013GXNSFEA053004]; Guangxi Projects {[}1355004-5, 2012GXNSFCB053004]; Guangxi Ministry of Education {[}201202ZD022, 201201ZD004]},
  funding-text               = {This work was supported by National Natural Science Foundation of China (NSFC) Key Project 81130046 (to JZ); NSFC81171993 (to YL) and NSFC81272415 (to YL); Guangxi Key Projects 2013GXNSFEA053004 (to JZ); Guangxi Projects 1355004-5 (to JZ) and 2012GXNSFCB053004 (to YL); Guangxi Ministry of Education 201202ZD022 (to YL) and 201201ZD004 (to JZ). The authors thank Ms. Xin Huang and Ms. Xiaolin Zhou for editing.},
  groups                     = {Metformin},
  journal-iso                = {Chin. J. Cancer},
  keywords                   = {Metformin; Signaling pathway; Cancer stem cell; Cancer},
  keywords-plus              = {ANTIDIABETIC DRUG METFORMIN; NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; STEM-CELLS; PANCREATIC-CANCER; IN-VITRO; PROSTATE-CANCER; MTOR PATHWAY; IGF-I},
  language                   = {English},
  number-of-cited-references = {128},
  oa                         = {Green Published, gold},
  orcid-numbers              = {Keller, Evan T/0000-0002-7592-7535 Yi, Yanhua/0000-0001-8690-952X},
  publisher                  = {SUN YAT SEN UNIV MED SCI WHO},
  research-areas             = {Oncology},
  researcherid-numbers       = {Keller, Evan T/M-1446-2016 ZHANG, JIAN/Q-6334-2018 Lu, Yi/J-6746-2018},
  times-cited                = {107},
  type                       = {Review},
  unique-id                  = {WOS:000396288600001},
  usage-count-last-180-days  = {1},
  usage-count-since-2013     = {29},
  web-of-science-categories  = {Oncology},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

﻿
@Article{Lin2023,
  author                     = {Lin, Huan and Ao, Haiyong and Guo, Guanghua and Liu, Mingzhuo},
  journal                    = {Journal of Inflammation Research},
  title                      = {The Role and Mechanism of Metformin in Inflammatory Diseases},
  year                       = {2023},
  pages                      = {5545-5564},
  volume                     = {16},
  abstract                   = {Metformin is a classical drug used to treat type 2 diabetes. With the
   development of research on metformin, it has been found that metformin
   also has several advantages aside from its hypoglycemic effect, such as
   anti-inflammatory, anti-aging, anticancer, improving intestinal flora,
   and other effects. The prevention of inflammation is critical because
   chronic inflammation is associated with numerous diseases of
   considerable public health. Therefore, there has been growing interest
   in the role of metformin in treating various inflammatory conditions.
   However, the precise anti-inflammatory mechanisms of metformin were
   inconsistent in the reported studies. Thus, this review aims to
   summarize various currently known possible mechanisms of metformin
   involved in inflammatory diseases and provide references for the
   clinical application of metformin.},
  address                    = {PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND},
  affiliation                = {Guo, GH; Liu, MZ (Corresponding Author), Nanchang Univ, Affiliated Hosp 1, Med Ctr Burn Plast \& Wound Repair, 17 Yongwai Zheng St, Nanchang, Jiangxi, Peoples R China. Lin, Huan; Guo, Guanghua; Liu, Mingzhuo, Nanchang Univ, Med Ctr Burn Plast \& Wound Repair, Affiliated Hosp 1, Nanchang, Peoples R China. Ao, Haiyong, East China Jiaotong Univ, Jiangxi Key Lab Nanobiomat, Nanchang, Jiangxi, Peoples R China. Ao, Haiyong, East China Jiaotong Univ, Sch Mat Sci \& Engn, Nanchang, Jiangxi, Peoples R China. Guo, Guanghua; Liu, Mingzhuo, Nanchang Univ, Affiliated Hosp 1, Med Ctr Burn Plast \& Wound Repair, 17 Yongwai Zheng St, Nanchang, Jiangxi, Peoples R China.},
  affiliations               = {Nanchang University; East China Jiaotong University; East China Jiaotong University; Nanchang University},
  author-email               = {ndyfy00655@ncu.edu.cn ndyfy05397@ncu.edu.cn},
  cited-references           = {Adar T, 2012, CLIN EXP IMMUNOL, V167, P252, DOI 10.1111/j.1365-2249.2011.04511.x. Aguayo-Mazzucato C, 2019, CELL METAB, V30, P129, DOI 10.1016/j.cmet.2019.05.006. Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X. Al-Hashem F, 2019, J CELL PHYSIOL, V234, P9328, DOI 10.1002/jcp.27616. Alfaras I, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0018-7. Algire C, 2012, CANCER PREV RES, V5, P536, DOI 10.1158/1940-6207.CAPR-11-0536. Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014. Andrews NP, 2010, GERONTOLOGY, V56, P390, DOI 10.1159/000268620. Arbab AAI, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.661380. Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767. Bharath LP, 2021, AM J PHYSIOL-CELL PH, V320, pC873, DOI 10.1152/ajpcell.00604.2020. Bilchick K, 2020, CARDIOVASC RES, V116, P1311, DOI 10.1093/cvr/cvz232. Bosi E, 2009, DIABETES OBES METAB, V11, P3, DOI 10.1111/j.1463-1326.2008.01031.x. Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598. Brandt A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43228-0. Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002. Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082. Cai J, 2020, J CELL MOL MED, V24, P3460, DOI 10.1111/jcmm.15027. Cai Q, 2022, HUM VACC IMMUNOTHER, DOI 10.1080/21645515.2022.2145102. Calixto MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076786. Camuzard O, 2019, J BONE ONCOL, V16, DOI 10.1016/j.jbo.2019.100235. Cao Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112794. Castaner O, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/4095789. Cenni V, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061415. Chen KH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0127-z. Chen KQ, 2015, EBIOMEDICINE, V2, P324, DOI 10.1016/j.ebiom.2015.03.001. Chen ML, 2016, MBIO, V7, DOI 10.1128/mBio.02210-15. Chen RJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122063. Chen S, 2022, THERANOSTICS, V12, P2722, DOI 10.7150/thno.71360. Chen XC, 2022, LUPUS SCI MED, V9, DOI 10.1136/lupus-2021-000611. Chen YF, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2488-y. Chen YC, 2011, HIGH ALT MED BIOL, V12, P371, DOI 10.1089/ham.2010.1088. Cheng DM, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-03036-5. Choi HJ, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/2905362. Chung MM, 2017, EXP CELL RES, V352, P75, DOI 10.1016/j.yexcr.2017.01.017. Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613. Davis Cindy D, 2016, Nutr Today, V51, P167, DOI 10.1097/NT.0000000000000167. de Araújo AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183506. de Mingo A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.368. de Oliveira S, 2019, J HEPATOL, V70, P710, DOI 10.1016/j.jhep.2018.11.034. Deng J, 2018, J CELL MOL MED, V22, P546, DOI 10.1111/jcmm.13342. Ding L, 2015, ONCOTARGET, V6, P36441, DOI 10.18632/oncotarget.5541. Dornas W, 2019, PHARMACOL RES, V141, P418, DOI 10.1016/j.phrs.2019.01.026. Du RH, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw037. Du RW, 2020, EXP BRAIN RES, V238, P2549, DOI 10.1007/s00221-020-05911-x. Ekström N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001076. El-Mahdy NA, 2021, IMMUNOPHARM IMMUNOT, V43, P192, DOI 10.1080/08923973.2021.1878214. El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223. Esteghamati A, 2013, CLIN NUTR, V32, P179, DOI 10.1016/j.clnu.2012.08.006. Fei Q, 2020, J MOL CELL CARDIOL, V145, P1, DOI 10.1016/j.yjmcc.2020.05.016. Filtjens J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22841-6. Frasca D, 2017, CLIN EXP IMMUNOL, V187, P64, DOI 10.1111/cei.12824. Fu MH, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1623-0. Gandellini P, 2014, ANTIOXID REDOX SIGN, V20, P1045, DOI 10.1089/ars.2013.5292. Gao JL, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101345. Gao Y, 2023, J CARDIOVASC PHARM, V82, P308, DOI 10.1097/FJC.0000000000001463. Gavillet M, 2015, AM J HEMATOL, V90, P1155, DOI 10.1002/ajh.24185. Geraghty P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00267. Giaccari A, 2021, DIABETES CARE, V44, P647, DOI 10.2337/dc20-1964. Glaría E, 2020, CURR OPIN PHARMACOL, V53, P55, DOI 10.1016/j.coph.2020.05.001. González A, 2020, CELL METAB, V31, P472, DOI 10.1016/j.cmet.2020.01.015. Guo WJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093321. Guo YL, 2022, INVEST OPHTH VIS SCI, V63, DOI 10.1167/iovs.63.1.30. He CG, 2020, DIABET METAB SYND OB, V13, P2081, DOI 10.2147/DMSO.S253494. Hirahara K, 2016, INT IMMUNOL, V28, P163, DOI 10.1093/intimm/dxw006. Huang KY, 2020, INT J BIOL SCI, V16, P2559, DOI 10.7150/ijbs.40823. Ilan Y, 2012, WORLD J GASTROENTERO, V18, P2609, DOI 10.3748/wjg.v18.i21.2609. Into T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01246-w. Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968. Iskandar R, 2017, EXP THER MED, V13, P1850, DOI 10.3892/etm.2017.4202. Janssen AFJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06674-4. Jiang MY, 2021, J INFLAMM RES, V14, P2681, DOI 10.2147/JIR.S306846. Jiang N, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.666631. Jiang WP, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060897. Jing YY, 2018, MOL CELL ENDOCRINOL, V461, P256, DOI 10.1016/j.mce.2017.09.025. Jung CH, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-41. Ka SM, 2016, FREE RADICAL BIO MED, V91, P10, DOI 10.1016/j.freeradbiomed.2015.12.003. Kabat AM, 2016, ELIFE, V5, DOI 10.7554/eLife.12444. Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014. Kamarudin MNA, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1495-2. Karnevi E, 2014, IMMUNOL CELL BIOL, V92, P543, DOI 10.1038/icb.2014.22. Kawanami D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124239. Kelly B, 2015, J BIOL CHEM, V290, P20348, DOI 10.1074/jbc.M115.662114. Kim DH, 2018, NUTR RES PRACT, V12, P20, DOI 10.4162/nrp.2018.12.1.20. Kim D, 2013, INT J MOL MED, V32, P1293, DOI 10.3892/ijmm.2013.1508. Kim JW, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1904-0. Kim MJ, 2014, MOL PHARMACOL, V86, P284, DOI 10.1124/mol.114.093039. Kulkarni AS, 2020, CELL METAB, V32, P15, DOI 10.1016/j.cmet.2020.04.001. Lau L, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00586-18. Ledderose C, 2018, J CLIN INVEST, V128, P3583, DOI 10.1172/JCI120972. Lee SY, 2017, J IMMUNOL, V198, P2661, DOI 10.4049/jimmunol.1403088. Lee SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135858. Li D, 2019, AGING-US, V11, P11084, DOI 10.18632/aging.102512. Li F, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166260. Li S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/3042726. Li SX, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.719589. Li XD, 2015, CELL RES, V25, P50, DOI 10.1038/cr.2014.150. Lin CC, 2013, AM J RESP CELL MOL, V49, P241, DOI 10.1165/rcmb.2012-0244OC. Lin CF, 2013, IMMUNOPHARM IMMUNOT, V35, P669, DOI 10.3109/08923973.2013.837059. Lingesh A, 2019, J ETHNOPHARMACOL, V233, P123, DOI 10.1016/j.jep.2018.12.039. Liso M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121862. Liu J, 2022, BMC ENDOCR DISORD, V22, DOI 10.1186/s12902-021-00921-4. Liu SK, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/7101407. Liu Y, 2016, PHARM BIOL, V54, P1173, DOI 10.3109/13880209.2015.1057652. Liu YY, 2019, AUTOPHAGY, V15, P493, DOI 10.1080/15548627.2018.1531196. Liu ZY, 2015, J BIOL CHEM, V290, P2312, DOI 10.1074/jbc.M114.616441. Liu ZY, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.640347. Loh CY, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00048. Long DE, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1932-5. Loza MJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-103. Lu GL, 2021, BIOMED PHARMACOTHER, V137, DOI 10.1016/j.biopha.2021.111286. Luo F, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0860-y. Luo Q, 2018, INT J CLIN EXP PATHO, V11, P2408. Luodan A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00102. Lv HM, 2017, REDOX BIOL, V12, P311, DOI 10.1016/j.redox.2017.03.001. Lv Q, 2015, LIFE SCI, V131, P23, DOI 10.1016/j.lfs.2015.03.003. Lv SY, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136715. MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367. Makino Y, 2021, DENT J-BASEL, V9, DOI 10.3390/dj9010007. Maneechotesuwan K, 2021, CLIN EXP ALLERGY, V51, P1553, DOI 10.1111/cea.13825. Mangold A, 2015, CIRC RES, V116, P1182, DOI 10.1161/CIRCRESAHA.116.304944. Marciano O, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010097. Marcum ZA, 2018, J GEN INTERN MED, V33, P155, DOI 10.1007/s11606-017-4219-3. Marek-Iannucci S, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.151981. Maulucci G, 2015, AUTOPHAGY, V11, P1905, DOI 10.1080/15548627.2015.1084455. Menegazzo L, 2018, ACTA DIABETOL, V55, P593, DOI 10.1007/s00592-018-1129-8. Mira JC, 2017, CRIT CARE MED, V45, P253, DOI {[}10.1097/CCM.0000000000002074, 10.1097/ccm.0000000000002074]. Mogavero A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16149-z. Mohamed MA, 2020, EPILEPSY BEHAV, V104, DOI 10.1016/j.yebeh.2019.106893. Moon J, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-02860-z. Moschen AR, 2012, GUT LIVER, V6, P411, DOI 10.5009/gnl.2012.6.4.411. Müller S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206764. Mummidi S, 2016, J MOL CELL CARDIOL, V98, P95, DOI 10.1016/j.yjmcc.2016.07.006. Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980. Napolitano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100778. Nassif RM, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10020319. Navrátilová A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85561-3. Nelson LE, 2012, AM J PHYSIOL-CELL PH, V303, pC4, DOI 10.1152/ajpcell.00296.2011. Nishimoto S, 2020, INFLAMM REGEN, V40, DOI 10.1186/s41232-020-00118-7. Niu C, 2019, AUTOPHAGY, V15, P843, DOI 10.1080/15548627.2019.1569913. Noguchi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35783-9. Noren Hooten N, 2016, AGING CELL, V15, P572, DOI 10.1111/acel.12469. O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862. Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607. Pan BH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09337-4. Parackova Z, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00661. Park MJ, 2016, TRANSL RES, V173, P115, DOI 10.1016/j.trsl.2016.03.006. Paunel-Görgülü A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17561-1. Peng C, 2018, CELL PHYSIOL BIOCHEM, V46, P2311, DOI 10.1159/000489621. Picone P, 2015, BBA-MOL CELL RES, V1853, P1046, DOI 10.1016/j.bbamcr.2015.01.017. Planas D, 2021, EBIOMEDICINE, V65, DOI 10.1016/j.ebiom.2021.103270. Poroyko VA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35405. Qi T, 2017, J MOL ENDOCRINOL, V59, P49, DOI 10.1530/JME-17-0066. Qu Z, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010178. Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586. Rodgers MA, 2014, ANTIOXID REDOX SIGN, V20, P495, DOI 10.1089/ars.2013.5347. Rymut SM, 2019, AM J PHYSIOL-LUNG C, V316, pL1081, DOI 10.1152/ajplung.00369.2018. Saber S, 2021, INFLAMMOPHARMACOLOGY, V29, P237, DOI 10.1007/s10787-020-00730-6. Saha S, 2020, MOLECULES, V25, DOI 10.3390/molecules25225474. Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383. Saladini S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010049. Santana PT, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00301. Schexnayder C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113692. Shaban L, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008576. Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781. Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009. Shin S, 2013, BIOMOL THER, V21, P35, DOI 10.4062/biomolther.2012.094. Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5. Singh N, 2019, ANN AFR MED, V18, P121, DOI 10.4103/aam.aam\_56\_18. Sofoluwe A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53058-9. Son HJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/973986. Song YM, 2015, AUTOPHAGY, V11, P46, DOI 10.4161/15548627.2014.984271. Soni C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01601. Sun B, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0054-1. Sun TL, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.10010. Sun XF, 2018, BIOL REPROD, V98, P208, DOI 10.1093/biolre/iox164. Sung JY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239976. Tan SC, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/6106572. Tao FL, 2022, KOREAN J PHYSIOL PHA, V26, P95, DOI 10.4196/kjpp.2022.26.2.95. Tyrrell DJ, 2021, NAT REV CARDIOL, V18, P58, DOI 10.1038/s41569-020-0431-7. van Beek AA, 2017, J LEUKOCYTE BIOL, V101, P811, DOI 10.1189/jlb.1HI0216-062RR. van den Bosch MHJ, 2021, OSTEOARTHR CARTILAGE, V29, P143, DOI 10.1016/j.joca.2020.10.006. Van Nostrand JL, 2020, GENE DEV, V34, P1330, DOI 10.1101/gad.339895.120. Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225. Vazirpanah N, 2019, ANN RHEUM DIS, V78, P663, DOI 10.1136/annrheumdis-2018-214656. Vinaik R, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa116. Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200. Wang HT, 2015, ARTHRITIS RHEUMATOL, V67, P3190, DOI 10.1002/art.39296. Wang WR, 2020, J CELL MOL MED, V24, P6658, DOI 10.1111/jcmm.15316. Wang X, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.691304. Wen J, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104308. Williamson L, 2019, AM J PHYSIOL-ENDOC M, V316, pE286, DOI 10.1152/ajpendo.00341.2018. Wong C, 2011, BRIEF BIOINFORM, V12, P1, DOI 10.1093/bib/bbq008. Woo SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091111. Wu HC, 2020, MOLECULES, V25, DOI 10.3390/molecules25071746. Wu QJ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3306-y. Wu YQ, 2022, ACTA PHARMACOL SIN, V43, P1360, DOI 10.1038/s41401-021-00759-5. Xia J, 2022, INT IMMUNOPHARMACOL, V113, DOI 10.1016/j.intimp.2022.109342. Xian HX, 2021, IMMUNITY, V54, P1463, DOI 10.1016/j.immuni.2021.05.004. Xiao N, 2022, ELIFE, V11, DOI 10.7554/eLife.74713. Xiong WF, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04235-0. Xu L, 2021, AM J PHYSIOL-GASTR L, V320, pG1034, DOI 10.1152/ajpgi.00431.2020. Xu YY, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0375-0. Xu Y, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-00703-5. Xu ZH, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232415508. Xue YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168670. Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017. Yan N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254321. Yan Z, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0013-x. Yang CS, 2012, INT NEUROUROL J, V16, P2, DOI 10.5213/inj.2012.16.1.2. Yang F, 2019, INT J BIOL SCI, V15, P1010, DOI 10.7150/ijbs.29680. Yang LY, 2022, J CANCER, V13, P1261, DOI 10.7150/jca.64170. Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995. Yang X, 2017, BBA-MOL BASIS DIS, V1863, P1984, DOI 10.1016/j.bbadis.2016.09.019. Yang Y, 2017, CELL PHYSIOL BIOCHEM, V42, P761, DOI 10.1159/000478068. Yi W, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00348-3. Yin M, 2021, ASN NEURO, V13, DOI 10.1177/17590914211003247. Yin Y, 2017, AGEING RES REV, V34, P3, DOI 10.1016/j.arr.2016.08.008. Yue W, 2015, ONCOTARGET, V6, P21208, DOI 10.18632/oncotarget.4126. Zhang J, 2020, AGING-US, V12, P24270, DOI 10.18632/aging.202143. Zhang YS, 2018, CANCER BIOL THER, V19, P735, DOI 10.1080/15384047.2018.1453971. Zhou CL, 2021, BMC NEUROSCI, V22, DOI 10.1186/s12868-021-00678-5. Zhou F, 2019, AM J TRANSL RES, V11, P199. Zhou JF, 2017, J PHARMACOL SCI, V135, P55, DOI 10.1016/j.jphs.2017.09.003. Zhou MX, 2018, EBIOMEDICINE, V35, P345, DOI 10.1016/j.ebiom.2018.08.035. Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663. Zhou X, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86522-6. Zhou XK, 2016, ONCOTARGET, V7, P873, DOI 10.18632/oncotarget.6418. Zhou Y, 2021, WORLD J DIABETES, V12, P19, DOI 10.4239/wjd.v12.i1.19. Zhu XD, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00646-9. Ziadlou R, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060932. Zindel J, 2020, ANNU REV PATHOL-MECH, V15, P493, DOI 10.1146/annurev-pathmechdis-012419-032847.},
  da                         = {2024-09-06},
  doc-delivery-number        = {FC5A4},
  doi                        = {10.2147/JIR.S436147},
  eissn                      = {1178-7031},
  funding-acknowledgement    = {Program of National Natural Science Foundation of China {[}81960352, 82160376, 81760342]; Youth Science Foundation of Jiangxi Province of China {[}20192BAB215029]; Key Research and Development Plan of the Science and Technology Department of Jiangxi Province of China {[}20171ACG70004]; Natural Science Foundation of Jiangxi Province {[}20212ACB214002]; Jiangxi Provincial Department of Science and Technology, Gan Po Talents 555 project leader talent training program {[}1210013001]},
  funding-text               = {Funding This study was supported by the Program of National Natural Science Foundation of China (Nos. 81960352, 82160376, and 81760342) ; Youth Science Foundation of Jiangxi Province of China (No. 20192BAB215029) ; the Key Research and Development Plan of the Science and Technology Department of Jiangxi Province of China (No. 20171ACG70004) ; the Natural Science Foundation of Jiangxi Province (No. 20212ACB214002) ; Jiangxi Provincial Department of Science and Technology, Gan Po Talents 555 project leader talent training program (No. 1210013001) .},
  groups                     = {Metformin},
  journal-iso                = {J. Inflamm. Res.},
  keywords                   = {metformin; AMPK; inflammation; mechanisms},
  keywords-plus              = {ISCHEMIA-REPERFUSION INJURY; KAPPA-B ACTIVATION; LIVER KINASE B1; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; IN-VITRO; MYOCARDIAL INJURY; AUTOPHAGY; AMPK},
  language                   = {English},
  number-of-cited-references = {232},
  oa                         = {Green Published, gold},
  publisher                  = {DOVE MEDICAL PRESS LTD},
  research-areas             = {Immunology},
  times-cited                = {4},
  type                       = {Review},
  unique-id                  = {WOS:001143551200001},
  usage-count-last-180-days  = {6},
  usage-count-since-2013     = {9},
  web-of-science-categories  = {Immunology},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

﻿
@Article{Kawoosa2022,
  author                     = {Kawoosa, Fizalah and Shah, Zafar A. and Masoodi, Shariq R. and Amin, Asif and Rasool, Roohi and Fazili, Khalid M. and Dar, Abid Hamid and Lone, Asif and ul Bashir, Samir},
  journal                    = {BMC ENDOCRINE DISORDERS},
  title                      = {Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes},
  year                       = {2022},
  month                      = {MAY 26},
  number                     = {1},
  volume                     = {22},
  abstract                   = {Background Organic cation transporter 1 primarily governs the action of
   metformin in the liver. There are considerable inter-individual
   variations in metformin response. In light of this, it is crucial to
   obtain a greater understanding of the influence of OCT1 expression or
   polymorphism in the context of variable responses elicited by metformin
   treatment. Results We observed that the variable response to metformin
   in the responders and non-responders is independent of isoform variation
   and mRNA expression of OCT-1. We also observed an insignificant
   difference in the serum metformin levels of the patient groups. Further,
   molecular docking provided us with an insight into the hotspot regions
   of OCT-1 for metformin binding. Genotyping of these regions revealed
   SNPs 156T>C and 1222A>G in both the groups, while as 181C>T and 1201G>A
   were found only in non-responders. The 181T>C and 1222A>G changes were
   further found to alter OCT-1 structure in silico and affect metformin
   transport in vitro which was illustrated by their effect on the
   activation of AMPK, the marker for metformin activity. Conclusion Taken
   together, our results corroborate the role of OCT-1 in the transport of
   metformin and also point at OCT1 genetic variations possibly affecting
   the transport of metformin into the cells and hence its subsequent
   action in responders and non-responders.},
  address                    = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
  affiliation                = {Shah, ZA (Corresponding Author), Sherikashmir Inst Med Sci, Dept Immunol \& Mol Med, Srinagar 190011, Jammu \& Kashmir, India. Kawoosa, Fizalah; Shah, Zafar A.; Rasool, Roohi, Sherikashmir Inst Med Sci, Dept Immunol \& Mol Med, Srinagar 190011, Jammu \& Kashmir, India. Masoodi, Shariq R., Sherikashmir Inst Med Sci, Dept Endocrinol, Srinagar 190011, Jammu \& Kashmir, India. Amin, Asif; Fazili, Khalid M., Univ Kashmir, Dept Biotechnol, Srinagar 190006, Jammu \& Kashmir, India. Dar, Abid Hamid, Cent Univ Kashmir, Dept Biotechnol, Ganderbal 191201, Jammu \& Kashmir, India. Lone, Asif, Univ Delhi, Deshbandhu Coll, Dept Biochem, Delhi 110019, India. ul Bashir, Samir, Univ Northern British Columbia, Dept Chem, Prince George, BC, Canada.},
  affiliations               = {Sher-i-Kashmir Institute of Medical Sciences; Sher-i-Kashmir Institute of Medical Sciences; University of Kashmir; Central University of Kashmir; University of Delhi; University of Northern British Columbia},
  article-number             = {140},
  author-email               = {zafaraminshah00@gmail.com},
  cited-references           = {Bankura B, 2016, INDIA J METABOLIC SY, V5, P198, DOI 10.4172/2167-0943.1000198. Becker ML, 2009, PHARMACOGENOMICS J, V9, P242, DOI 10.1038/tpj.2009.15. Chen LG, 2010, J PHARMACOL EXP THER, V335, P42, DOI 10.1124/jpet.110.170159. Cook MN, 2007, DIABETIC MED, V24, P350, DOI 10.1111/j.1464-5491.2007.02078.x. Dujic T, 2015, DIABETES, V64, P1786, DOI 10.2337/db14-1388. Florez JC, 2012, DIABETES CARE, V35, P1864, DOI 10.2337/dc11-2301. Florez Jose C, 2011, Curr Diab Rep, V11, P467, DOI 10.1007/s11892-011-0220-0. Hayer M, 1999, ANN HUM GENET, V63, P473, DOI 10.1046/j.1469-1809.2000.6430267.x. Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q. Hirst JA, 2012, DIABETES CARE, V35, P446, DOI 10.2337/dc11-1465. Kanto K, 2018, J DIABETES INVEST, V9, P587, DOI 10.1111/jdi.12755. Kerb R, 2002, PHARMACOGENETICS, V12, P591, DOI 10.1097/00008571-200211000-00002. Li QC, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/3402808. Mahrooz A, 2015, CLIN EXP MED, V15, P159, DOI 10.1007/s10238-014-0283-8. Nies AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022163. Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103. Riedmaier AE, 2013, TRENDS PHARMACOL SCI, V34, P126, DOI 10.1016/j.tips.2012.11.005. Seitz T, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0172-0. Sherifali D, 2010, DIABETES CARE, V33, P1859, DOI 10.2337/dc09-1727. Shikata E, 2007, J HUM GENET, V52, P117, DOI 10.1007/s10038-006-0087-0. Shokri F, 2016, INT J MOL CELL MED, V5, P1. Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558. Sur D, 2015, J Mol Genet Med, V9, P102, DOI {[}10.4172/1747-0862.C1.010, DOI 10.4172/1747-0862.C1.010]. van Leeuwen N, 2013, CLIN PHARMACOKINET, V52, P833, DOI 10.1007/s40262-013-0076-3. van Leeuwen N, 2012, DIABETOLOGIA, V55, P1971, DOI 10.1007/s00125-012-2537-x. Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735. Zhou Y, 2015, INT J CLIN EXP PATHO, V8, P9533.},
  da                         = {2024-09-07},
  doc-delivery-number        = {1N3NE},
  doi                        = {10.1186/s12902-022-01033-3},
  eissn                      = {1472-6823},
  groups                     = {Metformin},
  journal-iso                = {BMC Endocr. Disord.},
  keywords                   = {Organic cation transporter 1(OCT-1; Metformin; AMPK},
  keywords-plus              = {GENETIC-VARIATION; OCT1; POLYMORPHISMS; ATM; SLC22A1; CHINESE},
  language                   = {English},
  number-of-cited-references = {27},
  oa                         = {Green Published, gold},
  orcid-numbers              = {Lone, Asif/0000-0002-0292-240X},
  priority                   = {prio2},
  publisher                  = {BMC},
  readstatus                 = {read},
  research-areas             = {Endocrinology \& Metabolism},
  researcherid-numbers       = {Masoodi, Shariq/AAV-7265-2020 Fazili, d@61/I-9758-2017},
  times-cited                = {12},
  type                       = {Article},
  unique-id                  = {WOS:000800565100002},
  usage-count-last-180-days  = {0},
  usage-count-since-2013     = {2},
  web-of-science-categories  = {Endocrinology \& Metabolism},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

﻿
@Article{Jensen2022,
  author                     = {Jensen, Ole and Gebauer, Lukas and Brockmoeller, Juergen and Duecker, Christof},
  journal                    = {INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES},
  title                      = {Relationships between Inhibition, Transport and Enhanced Transport via the Organic Cation Transporter 1},
  year                       = {2022},
  month                      = {FEB},
  number                     = {4},
  volume                     = {23},
  abstract                   = {The organic cation transporter 1 (OCT1, SLC22A1) transports a large
   number of structurally diverse endogenous and exogenous substrates.
   There are numerous known competitive and non-competitive inhibitors of
   OCT1, but there are no studies systematically analyzing the relationship
   between transport, stimulation, and inhibition. Here, we tested in vitro
   OCT1 inhibition by OCT1 substrates and transport of OCT1 inhibitors
   under uniform analytical conditions. Beyond inhibition testing with two
   model substrates, we tested nine additional OCT1 substrates for their
   mutual inhibition. Inhibition of ASP(+) uptake by most OCT1 substrates
   was weak. The model substrate sumatriptan, with its moderately stronger
   inhibitability, was used to confirm this. Interestingly, OCT1 substrates
   exhibiting stronger OCT1 inhibition were mainly biaromatic
   beta-agonistic drugs, such as dobutamine, fenoterol, ractopamine and
   ritodrine. Biaromatic organic cations were both, strong inhibitors and
   good substrates, but many OCT1 substrates showed little pairwise
   inhibition. Surprisingly, sumatriptan did significantly enhance
   dobutamine uptake. This effect was concentration dependent and
   additional experiments indicated that efflux inhibition may be one of
   the underlying mechanisms. Our data suggests, that OCT1 substrates are
   mainly weak OCT1 inhibitors and among those inhibiting well,
   noncompetitive inhibition could be responsible. Weak competitive
   inhibition confirms that OCT1 inhibition screenings poorly predict OCT1
   substrates. Additionally, we showed that the OCT1 substrate sumatriptan
   can enhance uptake of some other OCT1 substrates. OCT1 transport
   stimulation was already observed earlier but is still poorly understood.
   Low OCT1 uptake inhibition and strong OCT1 efflux inhibition could be
   mechanisms exploitable for enhancing transport.},
  address                    = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
  affiliation                = {Dücker, C (Corresponding Author), Univ Med Ctr Gottingen, Inst Clin Pharmacol, D-37075 Gottingen, Germany. Jensen, Ole; Gebauer, Lukas; Brockmoeller, Juergen; Duecker, Christof, Univ Med Ctr Gottingen, Inst Clin Pharmacol, D-37075 Gottingen, Germany.},
  affiliations               = {University of Gottingen; UNIVERSITY GOTTINGEN HOSPITAL},
  article-number             = {2007},
  author-email               = {ole.jensen@med.uni-goettingen.de lukas.gebauer@med.uni-goettingen.de jbrockm@gwdg.de christof.duecker@med.uni-goettingen.de},
  cited-references           = {Abebe BT, 2020, J CLIN PHARMACOL, V60, P312, DOI 10.1002/jcph.1523. Ahlin G, 2008, J MED CHEM, V51, P5932, DOI 10.1021/jm8003152. Amphoux A, 2006, NEUROPHARMACOLOGY, V50, P941, DOI 10.1016/j.neuropharm.2006.01.005. Amphoux A, 2010, EUR J PHARMACOL, V634, P1, DOI 10.1016/j.ejphar.2010.02.012. Chen EC, 2017, J MED CHEM, V60, P2685, DOI 10.1021/acs.jmedchem.6b01317. Cho SK, 2014, BRIT J CLIN PHARMACO, V78, P1426, DOI 10.1111/bcp.12476. Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629. Ekins S, 2012, CLIN PHARMACOL THER, V92, P661, DOI 10.1038/clpt.2012.164. Gebauer L, 2022, BIOCHEM PHARMACOL, V197, DOI 10.1016/j.bcp.2021.114871. Gebauer L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222312816. Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254. Gorboulev V, 2005, MOL PHARMACOL, V67, P1612, DOI 10.1124/mol.104.008821. Gründemann D, 2002, BRIT J PHARMACOL, V137, P910, DOI 10.1038/sj.bjp.0704926. Hacker K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136451. Hendrickx R, 2013, J MED CHEM, V56, P7232, DOI 10.1021/jm400966v. Hilgendorf C, 2007, DRUG METAB DISPOS, V35, P1333, DOI 10.1124/dmd.107.014902. Jensen O, 2021, J MED CHEM, V64, P2762, DOI 10.1021/acs.jmedchem.0c02047. Jensen O, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.609811. Jensen O, 2020, BIOCHEM PHARMACOL, V171, DOI 10.1016/j.bcp.2019.113731. Jensen O, 2020, CLIN PHARMACOL THER, V107, P628, DOI 10.1002/cpt.1666. Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2. Keller T, 2019, MOL PHARMACOL, V95, P169, DOI 10.1124/mol.118.113498. Koepsell H, 2021, EXPERT OPIN DRUG MET, V17, P635, DOI 10.1080/17425255.2021.1915284. Koepsell H, 2020, PHARMACOL REV, V72, P253, DOI 10.1124/pr.118.015578. Koepsell H, 2019, BIOL CHEM, V400, P195, DOI 10.1515/hsz-2018-0191. Liang XM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2002907. Liu FY, 2019, SCIENCE, V364, P1184, DOI 10.1126/science.aaw7611. Longo N, 2016, ANN NUTR METAB, V68, P5, DOI 10.1159/000448321. Matthaei J, 2016, CLIN PHARMACOL THER, V99, P633, DOI 10.1002/cpt.317. Meyer MJ, 2020, DRUG METAB DISPOS, V48, P1380, DOI 10.1124/dmd.120.000170. Meyer MJ, 2019, J MED CHEM, V62, P9890, DOI 10.1021/acs.jmedchem.9b01301. Meyer MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189521. Minuesa G, 2009, J PHARMACOL EXP THER, V329, P252, DOI 10.1124/jpet.108.146225. Morse BL, 2020, DRUG METAB DISPOS, V48, P93, DOI 10.1124/dmd.119.088781. Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103. Pereira JND, 2014, AAPS J, V16, P1247, DOI 10.1208/s12248-014-9649-9. Popp C, 2005, MOL PHARMACOL, V67, P1600, DOI 10.1124/mol.104.008839. Sandoval PJ, 2018, MOL PHARMACOL, V94, P1057, DOI 10.1124/mol.117.111443. Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275. Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354. Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334. Tzvetkov MV, 2018, CLIN PHARMACOL THER, V103, P868, DOI 10.1002/cpt.812. Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106. Venkatasubramanian R, 2014, PHARMACOGENOMICS, V15, P1297, DOI {[}10.2217/PGS.14.99, 10.2217/pgs.14.99]. Vivian D, 2014, EUR J PHARM SCI, V64, P44, DOI 10.1016/j.ejps.2014.08.007. Volk C, 2009, MOL PHARMACOL, V76, P275, DOI 10.1124/mol.109.054783.},
  da                         = {2024-09-07},
  doc-delivery-number        = {0B7UI},
  doi                        = {10.3390/ijms23042007},
  eissn                      = {1422-0067},
  funding-acknowledgement    = {Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) {[}461080000, 437446827]; Open Access Publication Funds of the Gottingen University},
  funding-text               = {This research was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-project numbers: 461080000 and 437446827. We acknowledge support by the Open Access Publication Funds of the Gottingen University.},
  journal-iso                = {Int. J. Mol. Sci.},
  keywords                   = {OCT1; inhibition; transport; potentiation; enhancement},
  keywords-plus              = {AMINO-ACIDS; IN-VITRO; OCT1; IDENTIFICATION; AFFINITY; EXPRESSION; METFORMIN; LIVER; ROCT1; CFTR},
  language                   = {English},
  number-of-cited-references = {46},
  oa                         = {gold, Green Published},
  orcid-numbers              = {Jensen, Ole/0000-0001-9903-4769 Gebauer, Lukas/0000-0003-2823-4178},
  publisher                  = {MDPI},
  research-areas             = {Biochemistry \& Molecular Biology; Chemistry},
  times-cited                = {13},
  type                       = {Article},
  unique-id                  = {WOS:000774835000001},
  usage-count-last-180-days  = {1},
  usage-count-since-2013     = {8},
  web-of-science-categories  = {Biochemistry \& Molecular Biology; Chemistry, Multidisciplinary},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

@Comment{jabref-meta: databaseType:bibtex;}

@Comment{jabref-meta: grouping:
0 AllEntriesGroup:;
1 StaticGroup:Metformin\;0\;0\;0xff0000ff\;MDI_KEY\;\;;
1 StaticGroup:AMPK\;0\;1\;0xb3e6b3ff\;MDI_AIRBALLOON\;\;;
}
